Eyelid solution

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Care Pharmaceuticals Pty Ltd

classe:

Class I

Fabriqué par:

Schalcon Spa Via Di Saponara 614, Rome, 00125 Italy

Domaine thérapeutique:

58837 - Eyelid solution

indications thérapeutiques:

A liposomal phospholipid suspension intended to be applied to the eyelids for the treatment and relief of symptoms of dry, itchy and irritated eyes due to tear film deficiencies through the provision of supplemental lipids on the eyelid margin to stabilize the natural tear film lipid layer.

Statut de autorisation:

A

Date de l'autorisation:

2014-12-01